Evidence map›Paper›PMID 31097026›Full record

ReviewParasites & vectors2019

Metamorphoses of Lyme disease spirochetes: phenomenon of Borrelia persisters.

Natalie Rudenko, Maryna Golovchenko, Katerina Kybicova, Marie Vancova

Open access · goldAbstract readReview
In one paragraph

Review in Parasites & vectors, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 84 citations in OpenAlex.

  1. Colonization of 3D-organotypic human skin by the Lyme Disease pathogen,bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Borrelia surface proteins: new horizons in Lyme disease diagnosis.Applied microbiology and biotechnology · 2025
    Review
  4. Article
  5. Tick-Borne Bacterial Diseases in Europe: Threats to public health.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Review
  6. Secreted Metabolites fromMicroorganisms · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in cellular and infection microbiology · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Concurrent Infection of the Human Brain with MultipleInternational journal of molecular sciences · 2023
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Natalie RudenkoBiology Centre CAS, Institute of Parasitology, Branisovska 31, 37005, Ceske Budejovice, Czech Republic. natasha@paru.cas.cz.
Maryna GolovchenkoBiology Centre CAS, Institute of Parasitology, Branisovska 31, 37005, Ceske Budejovice, Czech Republic.
Katerina KybicovaNational Institute of Public Health, Srobarova 48, 100 42, Prague 10, Czech Republic.
Marie VancovaBiology Centre CAS, Institute of Parasitology, Branisovska 31, 37005, Ceske Budejovice, Czech Republic.
Institute of Parasitology · CZCzech Academy of Sciences, Biology Centre · CZNational Institute of Public Health · CZ

Funding

Ministry of Education, Youth and Sport of the Czech Republic CZ.02.1.01/0.0/0.0/16_013/0001775Ministry of Education, Youth and Sport of the Czech Republic LM2015062 Czech-BioImagingMinistry of Health of the Czech Republic NV19-05-00191
6 · The paper itself

Abstract

The survival of spirochetes from the Borrelia burgdorferi (sensu lato) complex in a hostile environment is achieved by the regulation of differential gene expression in response to changes in temperature, salts, nutrient content, acidity fluctuation, multiple host or vector dependent factors, and leads to the formation of dormant subpopulations of cells. From the other side, alterations in the level of gene expression in response to antibiotic pressure leads to the establishment of a persisters subpopulation. Both subpopulations represent the cells in different physiological states. "Dormancy" and "persistence" do share some similarities, e.g. both represent cells with low metabolic activity that can exist for extended periods without replication, both constitute populations with different gene expression profiles and both differ significantly from replicating forms of spirochetes. Persisters are elusive, present in low numbers, morphologically heterogeneous, multi-drug-tolerant cells that can change with the environment. The definition of "persisters" substituted the originally-used term "survivors", referring to the small bacterial population of Staphylococcus that survived killing by penicillin. The phenomenon of persisters is present in almost all bacterial species; however, the reasons why Borrelia persisters form are poorly understood. Persisters can adopt varying sizes and shapes, changing from well-known forms to altered morphologies. They are capable of forming round bodies, L-form bacteria, microcolonies or biofilms-like aggregates, which remarkably change the response of Borrelia to hostile environments. Persisters remain viable despite aggressive antibiotic challenge and are able to reversibly convert into motile forms in a favorable growth environment. Persisters are present in significant numbers in biofilms, which has led to the explanation of biofilm tolerance to antibiotics. Considering that biofilms are associated with numerous chronic diseases through their resilient presence in the human body, it is not surprising that interest in persisting cells has consequently accelerated. Certain diseases caused by pathogenic bacteria (e.g. tuberculosis, syphilis or leprosy) are commonly chronic in nature and often recur despite antibiotic treatment. Three decades of basic and clinical research have not yet provided a definite answer to the question: is there a connection between persisting spirochetes and recurrence of Lyme disease in patients?

Indexed as

Anti-Bacterial AgentsBiofilmsBorrelia burgdorferi GroupHumansLyme DiseaseMicrobial ViabilityRecurrenceAnti-Bacterial AgentsAntibiotic treatmentBiofilmBorrelia burgdorferiDormant formsLyme diseasePersistent infectionPersistersRound bodies

Identifiers

PMID31097026
PMCPMC6521364
OpenAlexW2947856274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.